NEW YORK (Reuters Health) – After surgically induced remission of Crohn’s disease, treatment with mesalamine reduces the risk of relapse somewhat; sulfasalazine, however, has no apparent benefit, according…
NEW YORK (Reuters Health) – While contact isolation precautions are recommended for all patients colonized or infected with vancomycin-resistant enterococci (VRE), a European study shows that isolation is…
NEW YORK (Reuters Health) – The 2010 Update of the practice parameter on the diagnosis and management of anaphylaxis emphasizes education and self-administration of epinephrine for patients with…
NEW YORK (Reuters Health) – As long as eligibility criteria are strictly followed, it is safe to let “real world” patients undergoing percutaneous coronary intervention go home on…
NEW YORK (Reuters Health) – The use of angiotensin blocking therapy before cardiac surgery is not associated with postoperative atrial fibrillation (AF), researchers report in the August American…
NEW YORK (Reuters Health) – In high-risk patients having percutaneous coronary intervention for ST-segment elevation acute myocardial infarction (STEMI), bivalirudin was more effective than unfractionated heparin plus a…
NEW YORK (Reuters Health) – Major surgery often leads to transient thyroid hormone derangements. When it does, short-duration T3 therapy has no apparent benefit, according to a new…
NEW YORK (Reuters Health) – Gynecologic side effects of the third-generation selective estrogen receptor modulator lasofoxifene are generally acceptable, researchers report, and “contribute to an overall favorable benefit-risk…
NEW YORK (Reuters Health) – Elderly patients with heart failure have an increasing mortality risk as their dose of furosemide increases, after taking into account multiple confounders, a…
NEW YORK (Reuters Health) – Among couples wanting to conceive, the routine practice of having men with inflammatory bowel disease discontinue thiopurine medications is not necessary, a Spanish…